机译:地西他滨治疗10天的老年AML患者的临床反应和miR-29b预测意义
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Human Cancer Genetics, Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210 Center for Biostatistics, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Human Cancer Genetics, Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Human Cancer Genetics, Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
College of Pharmacy, Ohio State University, Columbus, OH, 43210;
Department of Pathology, Ohio State University, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210 College of Pharmacy, Ohio State University, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Human Cancer Genetics, Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
Division of Hematology and Oncology, Department of Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210 Division of Human Cancer Genetics, Department of Molecular Virology, Immunology, and Medical Genetics, Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210;
methylation; microRNA; azanucleoside;
机译:多维分析鉴定了对老年AML患者在老年患者中对酵母治疗的免疫签名
机译:免疫签名的多维分析预测老年AML患者对Defitabine治疗的反应
机译:Glasdibplus低剂量ARA-C,氮杂氨酸和Defitabine的临床反应在急性髓性白血病(AML)患者中没有资格获得密集化疗:使用间接治疗比较(ITC)方法的比较效果
机译:BIVENTRICULAL PACING:如何预测单人患者的临床反应?
机译:2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床,组织病理学和生物学参数的预后意义
机译:地西他滨治疗10天的老年AML患者的临床反应和miR-29b预测意义
机译:地西他滨治疗10天的老年AML患者的临床反应和miR-29b预测意义